Quantitative Structure-Activity Relationship of Various Endogenous Estrogen Metabolites for Human Estrogen Receptor α and β Subtypes: Insights into the Structural Determinants Favoring a Differential Subtype Binding
The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
To search for endogenous estrogens that may have preferential binding affinity for human estrogen receptor (ER) α or β subtype and also to gain insights into the structural determinants favoring differential subtype binding, we studied the binding affinities of 74 natural or synthetic estrogens, including more than 50 steroidal analogs of estradiol-17β (E2) and estrone (E1) for human ERα and ERβ. Many of the endogenous estrogen metabolites retained varying degrees of similar binding affinity for ERα and ERβ, but some of them retained differential binding affinity for the two subtypes. For instance, several of the D-ring metabolites, such as 16α-hydroxyestradiol (estriol), 16β-hydroxyestradiol-17α, and 16-ketoestrone, had distinct preferential binding affinity for human ERβ over ERα (difference up to 18-fold). Notably, although E2 has nearly the highest and equal binding affinity for ERα and ERβ, E1 and 2-hydroxyestrone (two quantitatively predominant endogenous estrogens in nonpregnant woman) have preferential binding affinity for ERα over ERβ, whereas 16α-hydroxyestradiol (estriol) and other D-ring metabolites (quantitatively predominant endogenous estrogens formed during pregnancy) have preferential binding affinity for ERβ over ERα. Hence, facile metabolic conversion of parent hormone E2 to various metabolites under different physiological conditions may serve unique functions by providing differential activation of the ERα or ERβ signaling system. Lastly, our computational three-dimensional quantitative structure-activity relationship/comparative molecular field analysis of 47 steroidal estrogen analogs for human ERα and ERβ yielded useful information on the structural features that determine the preferential activation of the ERα and ERβ subtypes, which may aid in the rational design of selective ligands for each human ER subtype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“E2 has the highest affinity for ERα and ERβ and is thus considered the strongest estrogen (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
In the citing paper
“E1 and E3 are weaker estrogens, with higher affinity for ERα and ERβ, respectively (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
In the citing paper
“E2, or 17β-estradiol, is the predominant estrogen in premenopausal women, and it is the more biologically active form as it has a higher affinity for estrogen receptors than other estrogen forms during reproductive years (121).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [121]
Citations
Cites
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous system
Shughrue, P. J., Lane, M. V., & Merchenthaler, I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971201)388:4<507::aid-cne1>3.0.co;2-6 · Cited by 2,259
Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 1,996
Sequence and Expression of Human Estrogen Receptor Complementary DNA
Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., & Shine, J. (1986) · Science · doi:10.1126/science.3753802 · Cited by 1,311
Human Estrogen Receptor β-Gene Structure, Chromosomal Localization, and Expression Pattern1
Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjöld, M., & Gustafsson, J.-A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4470 · Cited by 1,074
Research works printed but not linked: 4
- Katzenellenbogen, 1982, In vivo and in vitro steroid receptor assays in the design of estrogen pharmaceuticals, 93
- Fishman, 1981, Biological action of catecholestrogens, J Endocr, 85, 59P
- MacLusky, 1983, Catechol estrogens and estrogen receptors, 151
- Fanchenko, 1979, The specificity of human estrogen receptor, Acta Endocrinol, 7, 232
Cited by
Items 101–200 of 274
Suvorov, A., & Waxman, D. J. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.008 · Cited by 26
Maiti, S., & Nazmeen, A. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0826-x · Cited by 27
Estrogenic activity of constituents from the rhizomes of Rheum undulatum Linné
Park, S., Kim, N.-H., Kwak, H. J., Jeong, E. J., & Kim, S. H. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.063 · Cited by 23
Bahia, W., Soltani, I., Haddad, A., Soua, A., Radhouani, A., Mahdhi, A., & Ferchichi, S. (2020) · Gene · doi:10.1016/j.gene.2020.144406 · Cited by 22
Wang, P., Wen, Y., Han, G., Sidhu, P. K., & Zhu, B. T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00467.x · Cited by 23
“Based on our recent study (Zhu et al., 2006), the C-3 hydroxyl group appears to be a relatively more important determinant of binding strength compared with the C-17b hydroxyl group because 17-deoxyoestrone (an analogue of E2 with the 17-hydroxyl group removed) still retained considerable binding…”
BackgroundMethodInfluentialSelf-citationFu, X., Wang, P., & Zhu, B. T. (2010) · Biochemistry · doi:10.1021/bi101451g · Cited by 22
Self-citationMachado‐Linde, F., Pelegrín, P., Sánchez-Ferrer, M. L., Leon, J., Cascales-Campos, P. A., & Parrilla, J. J. (2012) · Reproductive Sciences · doi:10.1177/1933719112446080 · Cited by 22
“5% of E2 and due to this low affinity in the breast cancer cell line MCF7 (which has ER expression), very low concentrations of 2-ME2 caused stimulation of proliferation and growth, while high concentrations induces the expected inhibitory growing actions of 2-ME2.(64,103,104) 2-Methoxyestradiol is also able to activa…”
BackgroundWang, P., Bai, H., & Zhu, B. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012316 · Cited by 22
“30 kcal/mol, they were truncated to this value, an empirical approach that has been adopted in many similar studies [29].”
MethodSelf-citationPosritong, S., Hong, J. M., Eleniste, P. P., McIntyre, P. W., Wu, J. L., Himes, E. R., Patel, V., Kacena, M. A., & Bruzzaniti, A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.02.005 · Cited by 23
“It has been shown that raloxifene preferentially binds ERα with approximately 3.5 fold higher affinity than ERβ (Zhu et al., 2006).”
BackgroundInfluentialBiosynthesis of estetrol in human pregnancy: Potential pathways
Stanczyk, F. Z., & Archer, D. F. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106359 · Cited by 26
Wang, H., Hou, M., Liao, L., Li, P., Chen, T., Wang, P., & Zhu, B. T. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00261 · Cited by 21
Self-citationThe Effect of Estrogen Compounds on Human Embryoid Bodies
Kim, H., Kim, Y. Y., Ku, S., Kim, S. H., Choi, Y. M., & Moon, S. Y. (2012) · Reproductive Sciences · doi:10.1177/1933719112462630 · Cited by 23
Honma, N., Yamamoto, K., Ohnaka, K., Morita, M., Toyomura, K., Kono, S., Muramatsu, M., Arai, T., Ueki, T., Tanaka, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27688 · Cited by 21
“The binding affinity of a representative isoflavone, genistein, for ER-b1 is more than 10 times higher than that for ER-a, and almost the same as the affinity of estradiol for ER-b1 and about 40 times higher than that of estrone.(36,37) As described above, ER-b1 was expressed more frequently in epithelia of colon canc…”
ResultEstrogen Metabolism and Mammographic Density in Postmenopausal Women: A Cross-Sectional Study
Fuhrman, B. J., Brinton, L. A., Pfeiffer, R. M., Xu, X., Veenstra, T. D., Teter, B. E., Byrne, C., Dallal, C. M., Barba, M., Muti, P. C., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0247 · Cited by 21
“1) with different affinities for estrogen receptors (20).”
BackgroundFuhrman, B. J., Xu, X., Falk, R. T., Hankinson, S. E., Veenstra, T. D., Keefer, L. K., & Ziegler, R. G. (2010) · The International Journal of Biological Markers · doi:10.5301/jbm.2010.6086 · Cited by 23
“Estrogens and estrogen metabolites (EM) vary with respect to their availability to target tissues (6), affinity with estrogen receptors (7), and susceptibility to conversion into reactive, genotoxic species (8).”
BackgroundBerghella, A. M., Contasta, I., Beato, T. D., & Pellegrini, P. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-24 · Cited by 23
“Estradiol binds both estrogen receptor-(ER)α and ERβ with high and equal affinities, while estrone preferentially binds ERα at a 5-fold higher affinity than ERβ [17].”
BackgroundVariants of estrogen-related genes and breast cancer risk in European and African American women
Quan, L., Hong, C., Zirpoli, G., Roberts, M., Khoury, T., Sucheston‐Campbell, L. E., Bovbjerg, D. H., Jandorf, L. H., Pawlish, K. S., Ciupak, G. L., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0250 · Cited by 23
Tang, Z., Liu, Z., Wan, Y., Wang, H., Dang, Z., & Liu, Y. (2021) · ACS ES&T Water · doi:10.1021/acsestwater.1c00109 · Cited by 20
Xiao, Y., Zhang, B., Cloyd, J. M., Alaimo, L., Xu, G., Du, S., Mao, Y., & Pawlik, T. M. (2022) · Cancers · doi:10.3390/cancers14133284 · Cited by 21
“Both receptors interact similarly with endogenous estrogens and play a role in the development and progression of multiple malignant diseases, including breast, prostate, endometrial, ovarian, colorectal and lung cancers [53,54].”
BackgroundAbdel-hamid, N. R., Mohammed, E. A.-M., Toraih, E. A., Kamel, M. M., Abdelhafiz, A. S., & Badr, F. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-50007-5 · Cited by 20
“ER activates a vast network of genes that promote breast cancer cell proliferation and survival 14 .”
BackgroundMethodInteraction force diagrams: new insight into ligand-receptor binding
Shadnia, H., Wright, J. S., & Anderson, J. M. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9250-3 · Cited by 20
Osteoporosis: From osteoscience to neuroscience and beyond
Kwan, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.001 · Cited by 21
Urinary estrogen metabolites and prostate cancer risk: A pilot study
Kosti, O., Xu, X., Veenstra, T. D., Hsing, A. W., Chu, L. W., Goldman, L., Bebu, I., Collins, S., Dritschilo, A., Lynch, J. H., et al. (2010) · The Prostate · doi:10.1002/pros.21262 · Cited by 21
“have shown a preferential binding capacity for ERb [7] which was shown to have a protective role within the prostate [9].”
BackgroundInfluentialKwa, M. J., Hussey, G. A., Novik, Y., Franke, A. A., Volkova, A., Flores, K., Blaser, M. J., Speyer, J. L., Oratz, R., Meyers, M. I., et al. (2025) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06338-z · Cited by 23
“They circulate in the bloodstream in free or protein-bound form and first undergo metabolism primarily in the liver, where they are conjugated (sulfation and glucuronidation), oxidized, reduced, and/or methylated (Zhu et al. 2006 ; Raftogianis et al. 2000 ).”
Läsche, M., Gallwas, J. K. S., & Gründker, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095050 · Cited by 26
Robb, E. L., & Stuart, J. A. (2013) · Phytotherapy Research · doi:10.1002/ptr.4970 · Cited by 20
“Certainly, affinity of the molecule for ERb is a factor: strong inductions of MnSOD were observed with resveratrol, coumestrol and genistein, all of which have high affinity and/or selectivity for ERb (versus ERa; Zhu et al. 2006, Yuan et al. 2011).”
BackgroundKaszkin-Bettag, M., Richardson, A., Rettenberger, R., & Heger, P. W. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.12.026 · Cited by 19
“This finding is similar to that found recently for the phytochemical genistein (derived from soy, and an active component in all soy-based herbal remedies), where a high specificity for the ERb has been demonstrated (Zhu et al., 2006).”
BackgroundResultInfluentialOster, A., Klein, T., Henn, C., Werth, R., Marchais‐Oberwinkler, S., Frotscher, M., & Hartmann, R. W. (2011) · ChemMedChem · doi:10.1002/cmdc.201000457 · Cited by 19
Wang, P., McInnes, C., & Zhu, B. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074615 · Cited by 19
Self-citationMolecular structural characteristics as determinants of estrogen receptor selectivity
Agatonović-Kuštrin, S., Turner, J., & Glass, B. D. (2008) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2008.04.008 · Cited by 18
Émond, J.-P., Caron, P., Pušić, M. N., Turcotte, V., Simonyan, D., Vogler, A., Osredkar, J., Rižner, T. L., & Guillemette, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1034614 · Cited by 23
“A component of pain in EMwas shown to be related to inflammatory damage of nerve fibers with neuroprotective roles for ERb (58–61).”
BackgroundInfluentialPerspicace, E., Giorgio, A., Carotti, A., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.026 · Cited by 17
Wang, P., Dang, L., & Zhu, B. T. (2015) · Steroids · doi:10.1016/j.steroids.2015.11.001 · Cited by 17
Self-citationLiebmann, M., Pfeifer, M. A., Grupe, K., & Scherneck, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126693 · Cited by 20
Mesquite pod extract modifies the reproductive physiology and behavior of the female rat
Retana‐Márquez, S., Aguirre, F. G., Alcantara, M., García-Díaz, E., Muñoz-Gutiérrez, M., Arteaga‐Silva, M., López, G. B., Romero, C., Chemineau, P., Keller, M., et al. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.001 · Cited by 20
Can a single model explain both breast cancer and prostate cancer?
Friedman, A. (2007) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-4-28 · Cited by 17
Pacheco-Velázquez, S. C., Ortega-Mejia, I. I., Vargas-Navarro, J. L., Padilla-Flores, J. A., Robledo‐Cadena, D. X., Tapia-Martínez, G., Castro, I. P., Aguilar-Ponce, J. L., Granados-Rivas, J. C., Moreno‐Sánchez, R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1018137 · Cited by 22
Development of a nanomechanical biosensor for analysis of endocrine disrupting chemicals
Dutta, P., Hill, K. L., Datskos, P. G., & Sepaniak, M. J. (2007) · Lab on a Chip · doi:10.1039/b704723a · Cited by 16
Huang, X., Hou, M., & Zhu, B. T. (2024) · Scientific Reports · doi:10.1038/s41598-024-74742-5 · Cited by 16
“In addition, the protective effect of catechol estrogens is markedly stronger than their parent hormones E 1 and E 2 , despite that fact that these catechol estrogens have much weaker estrogenic activity at the ERs than E 1 and E 256,58 .”
BackgroundSelf-citationThe immunosenescence clock: A new method for evaluating biological age and predicting mortality risk
Li, S., Wang, K., Wu, J., & Zhu, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102653 · Cited by 21
“Notably, 17 α -estradiol, an isomer of 17 β -estradiol, has been identified as a substance that prolongs the lifespan (Zhu et al., 2006).”
Xu, K., Al‐Soud, Y. A., Wetzel, M., Hartmann, R. W., & Marchais‐Oberwinkler, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.010 · Cited by 15
Arumugam, A., Lissner, E. A., & Lakshmanaswamy, R. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-66 · Cited by 15
Exogenous Estrogens as Breast Cancer Risk Factors: A Perspective
Malik, P., & Mukherjee, T. K. (2025) · Cancers · doi:10.3390/cancers17162680 · Cited by 15
“While E2 harbors nearly equal affinity to ER α and ER β , genistein, a popular phytoestrogen derived from soy products, exhibits a stronger affinity toward ER β [139,149,150].”
Predicting molecular initiating events using chemical target annotations and gene expression
Bundy, J. L., Judson, R., Williams, A. J., Grulke, C., Shah, I., & Everett, L. J. (2022) · BioData Mining · doi:10.1186/s13040-022-00292-z · Cited by 18
“On the other hand, there are well documented examples of ligands that display variable binding affinity for receptors that share considerable sequence homology [22].”
BackgroundAl‐Soud, Y. A., Marchais‐Oberwinkler, S., Frotscher, M., & Hartmann, R. W. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201200025 · Cited by 14
Lim, V. W., Lim, W., Zhang, Z., Li, J., Gong, Y., Seow, A., & Yong, E. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.05.019 · Cited by 14
Characteristics of adverse events of endocrine therapies among older patients with breast cancer
Honma, N., Makita, M., Saji, S., Mikami, T., Ogata, H., Horii, R., Akiyama, F., Iwase, T., & Ohno, S. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04674-8 · Cited by 16
Impact of pubertal onset on region‐specific Esr2 expression
Drzewiecki, C. M., Sellinger, E. P., & Juraska, J. M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13029 · Cited by 21
Chang, M., Peng, K.-W., Kastrati, I., Overk, C., Qin, Z., Yao, P., Bolton, J. L., & Thatcher, G. R. J. (2007) · Endocrinology · doi:10.1210/en.2006-1568 · Cited by 14
“For comparison, the catechol estrogens, 4-OHE2 and 4-OHE, which have much lower oxidative lability, show approximately 5- to 10-fold diminished potency in ER ligand binding and Ishikawa-AP activity, compared with the parent estrogens (12), whereas the ER RBA values recently reported for 4-OHE, 4-OHE2, and 4-MeOE2 are…”
Pande, P., Fleck, S. C., Twaddle, N. C., Churchwell, M. I., Doerge, D. R., & Teeguarden, J. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.12.013 · Cited by 13
Wang, P., & Zhu, B. T. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.032 · Cited by 13
Self-citationSalum, L. B., Polikarpov, I., & Andricopulo, A. D. (2007) · SAR and QSAR in environmental research · doi:10.1080/10629360701698811 · Cited by 13
Govan, J. M., McIver, A. L., Riggsbee, C., & Deiters, A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203222 · Cited by 12
Embryologic and hormonal contributors to prostate cancer in transgender women.
Gaglani, S., Purohit, R. S., Tewari, A. K., Kyprianou, N., & Lundon, D. (2022) · PubMed · Cited by 12
Estrogen Nitration Kinetics and Implications for Wastewater Treatment
Strande, L., Strand, S. E., Kalhorn, T. F., & Stensel, H. D. (2009) · Water Environment Research · doi:10.2175/106143009x407285 · Cited by 12
“Importantly, aromatic amines are several orders of magnitude less toxic than nitro-aromatics (RazoFlores et al., 1997), and amino-E1 also has significantly less estrogenic activity than E1 (Zhu et al., 2006).”
BackgroundEstradiol metabolism by gut microbiota in women’s depression pathogenesis: inspiration from nature
Zhang, W., Jia, J., Yang, Y., Ye, D., Li, Y., Li, D., & Wang, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1505991 · Cited by 17
Binding capacity of ER-α ligands and SERMs: comparison of the human, dog and cat.
Toniti, W., Suthiyotha, N., Puchadapirom, P., & Jenwitheesuk, E. (2011) · PubMed · Cited by 11
Type 2 17-β Hydroxysteroid Dehydrogenase as a Novel Target for the Treatment of Osteoporosis
Soubhye, J., Alard, I. C., Antwerpen, P. V., & Dufrasne, F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.74 · Cited by 11
Zhang, Q., Hao, X., Sun, X., Jia, Y.-C., Zhu, Y.-Y., Yang, Y. X., & Zhu, B. T. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177313 · Cited by 11
Self-citationMenopause-related changes in vascular signaling by sex hormones
Li, T., Thoen, Z. E., Applebaum, J. M., & Khalil, R. A. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103526 · Cited by 13
Structure and Hydrogen-Bonding Ability of Estrogens Studied in the Gas Phase
Morishima, F., Inokuchi, Y., & Ebata, T. (2013) · The Journal of Physical Chemistry A · doi:10.1021/jp407438j · Cited by 10
Chang, Y., Chen, J., Hor, C.-Y., Chuang, Y.-C., Yang, C., & Yang, C.-N. (2013) · International Journal of Medicinal Chemistry · doi:10.1155/2013/743139 · Cited by 14
Structure-Activity Relationships
Lakshmanan, M. (2019) · Introduction to Basics of Pharmacology and Toxicology · doi:10.1007/978-981-32-9779-1_13 · Cited by 10
Rozani, S., & Lykoudis, P. M. (2024) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2024.115795 · Cited by 9
The effect of transient sex hormone fluctuations on vascular endothelial function
Turner, C. G., & DuPont, J. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00174.2025 · Cited by 9
A Narrative Review on Breast Cancer Treatment Supported by Focused and Systemic Phytotherapy
Machado, H., Machado, J. P., Alves, C. H. F., Monteiro, M. D. C., Cruz, A., Pinho, C., Soares, C. M. D., Grosso, C., Rodrigues, J. M., & Criado, M. B. (2025) · Nutraceuticals · doi:10.3390/nutraceuticals5040037 · Cited by 10
Barta, B. A., Ruppert, M., Fröhlich, K., Cosenza‐Contreras, M., Oláh, A., Sayour, A. A., Kovács, K., Karvaly, G., Biniossek, M. L., Merkely, B. P., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03164-y · Cited by 11
“The majority of metabolites of both E1 and E2 are known to bind to estrogen receptor subtypes [48] and may contribute to sex-related differences.”
BackgroundSun, X., Hao, X., Jia, Y.-C., Zhang, Q., Zhu, Y.-Y., Yang, Y. X., & Zhu, B. T. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2024.100050 · Cited by 10
Self-citationAgouridas, V., Blazejewski, J., Cleeren, A., Laı̈os, I., Leclercq, G., & Magnier, E. (2007) · Steroids · doi:10.1016/j.steroids.2007.11.002 · Cited by 9
Microbial Metabolites in Cancer Promotion or Prevention
Cox‐York, K. A., Stoecker, E., Hamm, A. K., & Weir, T. L. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_15 · Cited by 10
Sex steroid hormone residues in milk and their potential risks for breast and prostate cancer
Gao, P., Li, C., Gong, Q., Liu, L., Qin, R., & Liu, J. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1390379 · Cited by 10
Zhang, L., Cao, C., Kapoor‐Kaushik, N., Lai, R. Y., Liao, J., Wang, G., Ariotti, N., Jin, D., & Stenzel, M. H. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00265 · Cited by 8
Yamabe, N., Kang, K. S., Lee, W., Kim, S., & Zhu, B. T. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00209.2013 · Cited by 8
“Our earlier study showed that E3 has a preferential binding affinity for ER over ER (by a factor of 3 to 1), whereas E2 has nearly the same binding affinity for both ER and ER (46).”
BackgroundSelf-citationContribution of the Gut and Vaginal Microbiomes to Gynecological Cancers
Jayshree, R. S., & Kumar, R. V. (2019) · Springer eBooks · doi:10.1007/978-981-13-3438-2_31 · Cited by 7
Cross-coupling of [ 11 C]methyllithium for 11 C-labelled PET tracer synthesis
Helbert, H., Antunes, I. F., Luurtsema, G., Szymański, W., Feringa, B. L., & Elsinga, P. H. (2020) · Chemical Communications · doi:10.1039/d0cc05392a · Cited by 8
Knutson, C. J., Pflug, N. C., Yeung, W., Grobstein, M., Patterson, E. V., Cwiertny, D. M., & Gloer, J. B. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c04659 · Cited by 8
Classification Models of Estrogen Receptor-B Ligands Based on PSO-Adaboost-SVM
Cheng, Z., & Zhang, Y. (2010) · Journal of Convergence Information Technology · doi:10.4156/jcit.vol5.issue2.8 · Cited by 8
“Zhu et al. studied the binding affinities of 74 natural or synthetic estrogens, including more than 50 steroidal analogs of estradiol-17β (E2) and estrone (E1) for human ERα and ERβ [22].”
BackgroundA workflow for identifying metabolically active chemicals to complement in vitro toxicity screening
Leonard, J. A., Tebes-Stevens, C. L., Mansouri, K., Chang, D. T., Pudukodu, H. S., Smith, S., & Tan, Y. (2017) · Computational Toxicology · doi:10.1016/j.comtox.2017.10.003 · Cited by 11
The first Pd-catalyzed Buchwald–Hartwig aminations at C-2 or C-4 in the estrone series
Bacsa, I., Szemerédi, D., Woelfling, J., Schneider, G., Fekete, L., & Mernyák, E. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.85 · Cited by 8
Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression
Émond, J.-P., Lacombe, L., Caron, P., Turcotte, V., Simonyan, D., Aprikian, A. G., Saad, F., Carmel, M., Chevalier, S., Guillemette, C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01376-z · Cited by 9
Grand, A. L., André-Leroux, G., Marteil, G., Duval, H., Sire, O., & Tilly, V. L. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00026 · Cited by 7
Zhou, R., Lai, Y.-L., Yamabe, N., Fukui, M., & Zhu, B. T. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2011.617791 · Cited by 7
Self-citationGrand, A. L., Bouter, A., Couturier, A., Mulner‐Lorillon, O., Goff, X. L., Chesnel, F., Sire, O., & Tilly, V. L. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.01.007 · Cited by 7
“This result well matches previous hERa ligand- and coactivator-binding affinity measurements performed in vitro [44,47,48].”
ResultEstrogen metabolites in the release of inflammatory mediators from human amnion-derived cells
Pavan, B., Paganetto, G., Dalpiaz, A., Biondi, C., & Lunghi, L. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.01.018 · Cited by 7
“Moreover, as a term of comparison, Table 1 reports the RBA values obtained by Zhu et al. (2006) for estradiol metabolite interaction towards human purified β-ERs.”
BackgroundInfluentialChanges in the gene expression pattern induced by 2-methoxyestradiol in the mouse uterus
Rincón‐Rodríguez, R. J., Oróstica, M. L., Diaz, P. S., Reuquén, P., Cárdenas, H. G., & Orihuela, P. A. (2013) · Endocrine · doi:10.1007/s12020-013-9921-2 · Cited by 7
Tang, Z., Liu, Z., Chen, W., Wang, C., Wu, Y., Wang, H., Dang, Z., & Liu, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20554-x · Cited by 8
Brook, N., Gill, J., Dharmarajan, A., Chan, A., & Dass, C. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415641 · Cited by 7
Kwak, H. J., Park, S., Kim, N.-H., Yoo, G., Jeong, E. J., & Kim, S. H. (2019) · Separation Science and Technology · doi:10.1080/01496395.2019.1621342 · Cited by 7
Hormone Regulation of Adult Hippocampal Neurogenesis in the Mammalian Brain
Barha, C. K., Barker, J. M., Brummelte, S., Epp, J. R., & Galea, L. A. M. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00067-x · Cited by 9
Jiang, X., Wang, P., Fu, X., & Zhu, B. T. (2008) · Steroids · doi:10.1016/j.steroids.2008.06.004 · Cited by 7
Self-citationEvaluation of the effects of estrogens on endometrial cancer cells of different grades
Pavlič, R., Pušić, M. N., & Rižner, T. L. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106762 · Cited by 6
García-Becerra, R., Berno, V., Ordaz‐Rosado, D., Sharp, Z. D., Cooney, A. J., Mancini, M. A., & Larrea, F. (2010) · Gene · doi:10.1016/j.gene.2010.03.007 · Cited by 5
“The ability of the ER to bind structurally diverse compoundsmight be partially attributed to the size and composition of the ligand-binding pocket (Brzozowski et al., 1997; Zhu et al., 2006).”
BackgroundAssociation of genetic polymorphisms with local steroid metabolism in human benign breasts
Lee, O., Fought, A. J., Shidfar, A., Heinz, R. E., Kmiecik, T. E., Gann, P. H., Khan, S. A., & Chatterton, R. T. (2021) · Steroids · doi:10.1016/j.steroids.2021.108937 · Cited by 6
Shintani, M., Mitsunaga, F., Shimabukuro, S., & Nakamura, S. (2015) · Food and Nutrition Sciences · doi:10.4236/fns.2015.612116 · Cited by 6
The A-CD analogue of 16β,17α-estriol is a potent and highly selective estrogen receptor β agonist
Sauvée, C., Schäfer, A., Sundén, H., Ma, J., Gustavsson, A., Burstein, E. S., & Olsson, R. (2013) · MedChemComm · doi:10.1039/c3md00194f · Cited by 6
Igarashi, T., Yokota, S., Aida, A., Nishimura, T., & Kitajima, S. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105900 · Cited by 4
Zhang, E. Y., & Zhu, B. T. (2014) · Endocrine Connections · doi:10.1530/ec-14-0080 · Cited by 5
Self-citationHuang, X., Yin, T., Song, M., & Pan, J. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.01.008 · Cited by 6
Zhou, Y., Yin, Z., Cui, J., Cao, Z., Wang, C., Gao, X., He, S., Fu, T., Fu, L., & Zhou, X. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112200 · Cited by 6
Graham, L. A., & Shaw, I. C. (2011) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2011.569899 · Cited by 5
“4 [32,33] and BPA preferentially binds with ER by a factor of 1.”
Background
Metadata
- Authors
- Zhu, B. T., Han, G.-Z., Shim, J.-Y., Wen, Y., & Jiang, X.-R.
- Affiliations
- University of South Carolina (US)
- North Carolina Central University (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 147
- Issue
- 9
- Pages
- 4132-4150
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2147478280
- Cited by
- 271
- References
- 62
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 17 · 2023: 13 · 2022: 12 · 2021: 15 · 2020: 10 · 2019: 12 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 15 · 2014: 14 · 2013: 15 · 2012: 18
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of South Carolina
- North Carolina Central University
- National Cancer Institute (R01CA092391, R01CA097109, R01-CA97109, R01 CA 92391)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
- Keywords
- estrogen receptor alpha, estrogen receptor beta, estradiol, estrone, 2-hydroxyestrone, steroid analogues, CoMFA, 3D-QSAR, estrogen metabolism, pregnancy
- MeSH terms
- Diethylstilbestrol, Estradiol, Estriol, Estrogen Antagonists, Estrogens, Estrone, Humans, Hydroxyestrones, Models, Molecular, Molecular Structure, Signal Transduction, Quantitative Structure-Activity Relationship, Estrogen Receptor alpha, Estrogen Receptor beta, Phytoestrogens, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.